Corgi
Active#2 worldwide · Neo-insurersEstimated valuation · Neo-insurers · United States
Full-stack commercial insurer for startups and founder-led businesses, underwriting and handling claims in-house for policies such as D&O, cyber, tech E&O and general liability.
Estimated valuation
AI · Neo-insurers ranking (worldwide)- Anchor
- Last known equity round: Series B1 · USD 106M · May 2026
- Published valuation
- USD 2.6bn · May 2026
An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Neo-insurers · worldwide | Top 39 | #2 | Edition 0 · Oct 2026 | 18 Dec 2026 |
| United States · all sectors | Radar | — | Edition 0 · October 2026 | 1 Jan 2027 |
Funding history
| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| May 2026 | Series B1 | USD 110M | Equity | TCV, Prime Capital, Zone 2 Ventures, Kindred Ventures, First Order Fund |
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Latest news
All funding or secondary sale news →Picked up from the press by Uback’s watch and summarised by Uback, with a link to the original article.
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Corgi as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in neo-insurers
Full neo-insurers ranking →Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.